Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis? [9]

Gut

Volumn 55, Issue 4, 2006, Pages 585-

  Tarantino, G ^a   Conca, P ^a   Ariello, M ^a   Mastrolia, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

ADULT; AGED; BODY MASS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFECTIOUS HEPATITIS; INSULIN RESISTANCE; LETTER; LOW CALORY DIET; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGED; ANTIVIRAL AGENTS; DIET; DRUG THERAPY, COMBINATION; ENERGY INTAKE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RIBAVIRIN; TREATMENT OUTCOME;

EID: 33645129025     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.086744     Document Type: Letter

References (1)

1. Park HS, Lee K. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med 2005;22:266-72.